Skip to content
The Investors Edge Logo small
  • Home
  • Mining
  • Energy
  • Biotech
  • Technology
  • US Markets
  • Contact
  • Subscribe
Contact Subscribe
  • Home
  • Mining
  • Energy
  • Biotech
  • Technology
  • US Markets
Friday, July 11th, 2025

    US Markets

  • Biden says he’s ‘forever grateful’ to forces in Afghanistan on two-year anniversary of exit

    US Markets | Aug 31, 2023

    Biden says he’s ‘forever grateful’ to forces in Afghanistan on two-year anniversary of exit

    Biden ordered the full withdrawal of approximately 3,000 U.S. troops from Afghanistan by Aug. 31 2021.

  • Stocks making the biggest moves midday: Tilray, Salesforce, CrowdStrike, Dollar General and more

    US Markets | Aug 31, 2023

    Stocks making the biggest moves midday: Tilray, Salesforce, CrowdStrike, Dollar General and more

    These are the stocks posting the largest moves in midday trading.

  • Giuliani loses support of billionaires Langone, Cooperman: ‘I wouldn’t give him a nickel’

    US Markets | Aug 31, 2023

    Giuliani loses support of billionaires Langone, Cooperman: ‘I wouldn’t give him a nickel’

    Rudy Giuliani will not be getting help from some of the top donors from his 2008 campaign for president, as they turn their backs on him.

  • Stocks making the biggest premarket moves: Dollar General, Salesforce, Palantir and more

    US Markets | Aug 31, 2023

    Stocks making the biggest premarket moves: Dollar General, Salesforce, Palantir and more

    These are the stocks posting the largest moves in the premarket.

  • Ozempic could be the next target of Medicare drug price negotiations – here’s why

    US Markets | Aug 31, 2023

    Ozempic could be the next target of Medicare drug price negotiations – here’s why

    Wall Street analysts expect Ozempic to be selected for price negotiations in 2025 due to the amount of money Medicare Part D already spends on the drug.

  • 61% of Americans are living paycheck to paycheck — inflation is still squeezing budgets

    US Markets | Aug 31, 2023

    61% of Americans are living paycheck to paycheck — inflation is still squeezing budgets

    More than half of all U.S. adults currently live paycheck to paycheck, according to a new report.

  • HHS calls for easing restrictions on marijuana, sending cannabis stocks higher

    US Markets | Aug 31, 2023

    HHS calls for easing restrictions on marijuana, sending cannabis stocks higher

    That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.

  • Autumn arrives earlier than ever for Starbucks and others with pumpkin menu items

    US Markets | Aug 31, 2023

    Autumn arrives earlier than ever for Starbucks and others with pumpkin menu items

    More restaurants and retailers including Starbucks, Dunkin’ Donuts and IHOP are launching their limited-time pumpkin items in August.

  • How to stop Meta from using some of your personal data to train generative AI models

    US Markets | Aug 30, 2023

    How to stop Meta from using some of your personal data to train generative AI models

    Facebook users can now delete their personal information found in the third-party sources that Meta uses to train generative artificial intelligence models.

  • Stocks making the biggest moves after hours: Salesforce, Okta, CrowdStrike, Five Below and more

    US Markets | Aug 30, 2023

    Stocks making the biggest moves after hours: Salesforce, Okta, CrowdStrike, Five Below and more

    These are the stocks posting the largest moves in extended trading.

  • Trump fraud case: New York attorney general says ‘mountain’ of evidence justifies summary judgment

    US Markets | Aug 30, 2023

    Trump fraud case: New York attorney general says ‘mountain’ of evidence justifies summary judgment

    Donald Trump and the Trump Organization are due to go to civil trial in October in a massive fraud lawsuit filed by New York Attorney General Letitia James.

  • Medicare drug price negotiations may have a muted impact on drugmakers in the near term

    US Markets | Aug 30, 2023

    Medicare drug price negotiations may have a muted impact on drugmakers in the near term

    Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives. 

  • Posts pagination

    Newer posts Page 1 … Page 50 … Page 155 Older posts
© 2025. All Rights Reserved. The Investor’s Edge. Powered by HomeTree Digital.
  • Twitter
  • facebook
  • Subscribe
  • Terms of Use
  • Do Not Sell or Share My Personal Information
  • Advertise
  • Privacy Policy

Contact us

Please enable JavaScript in your browser to complete this form.
Checkboxes
Loading

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.